AI Summary
The FDA proposed closing a regulatory loophole that allows the unrestricted use of in-vitro laboratory tests.
On Oct 3, 2023, the US Food and Drug Administration (FDA) proposed to close what critics call a loophole in the nation’s regulatory framework that allows the use of many in-vitro laboratory tests without government scrutiny.